gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
The drug binds CD3 on T cells to activate and redirect them to kill CD30+ tumor cells via immune synapse and TCR/CD3 signaling; CD3+ T cells are effectors, not targets.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
CD3 complex on T cells; chain not specified in trial info
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06018129
disease_id_num_tar_ref
850
drug_id_num_tar_ref
2340